JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 92.54%658.97M | ---- | 924.96%1.1B | ---- | 326.12%342.26M | ---- | 110.01%107.25M | ---- | 105.05%80.32M |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | 273.22%136.93M | ---- | -558.89%-288.04M | ---- | -3,446.39%-79.05M | ---- | -562.87%-43.72M | ---- | -72.26%-2.23M |
Impairment and provisions: | ---- | 878.95%372K | ---- | -74.40%86K | ---- | --38K | ---- | --336K | ---- | ---- |
-Other impairments and provisions | ---- | 878.95%372K | ---- | -74.40%86K | ---- | --38K | ---- | --336K | ---- | ---- |
Asset sale loss (gain): | ---- | -63.57%106K | ---- | 290.63%183K | ---- | 4,057.14%291K | ---- | -187.27%-96K | ---- | -83.33%7K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -63.57%106K | ---- | 290.63%183K | ---- | 4,057.14%291K | ---- | -187.27%-96K | ---- | -83.33%7K |
Depreciation and amortization: | ---- | 77.12%333.94M | ---- | 48.88%427.89M | ---- | 46.46%188.54M | ---- | 51.71%287.4M | ---- | 63.79%128.73M |
-Depreciation | ---- | 127.18%238.79M | ---- | 84.72%258.75M | ---- | 75.93%105.11M | ---- | 74.88%140.08M | ---- | 70.03%59.75M |
Exchange Loss (gain) | ---- | 96.69%-93K | ---- | 87.39%-1.09M | ---- | 40.18%-2.81M | ---- | -539.93%-8.63M | ---- | -901.02%-4.69M |
Special items | ---- | 21.17%588.4M | ---- | 52.67%1.07B | ---- | 71.56%485.6M | ---- | -63.53%701.53M | ---- | -83.44%283.05M |
Operating profit before the change of operating capital | ---- | 83.83%1.72B | ---- | 121.18%2.31B | ---- | 92.69%934.87M | ---- | 0.63%1.04B | ---- | 146.45%485.18M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---2.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | ---- | 9.88%-8.36M | ---- | -4.09%-5.29M | ---- | -133.15%-9.28M | ---- | -153.48%-5.08M | ---- | -173.13%-3.98M |
Accounts payable increase (decrease) | ---- | 1.33%-175.34M | ---- | 821.24%56.68M | ---- | -285.47%-177.7M | ---- | -102.29%-7.86M | ---- | -145.45%-46.1M |
prepayments (increase)decrease | ---- | -128.05%-38.87M | ---- | 830.36%123.93M | ---- | 58.70%138.58M | ---- | 103.30%13.32M | ---- | 188.70%87.32M |
Special items for working capital changes | ---- | -23.86%383.67M | ---- | ---- | ---- | --503.89M | ---- | ---- | ---- | ---- |
Cash from business operations | ---- | 35.00%1.88B | ---- | 137.89%2.48B | ---- | 166.14%1.39B | ---- | 5.87%1.04B | ---- | 154.48%522.42M |
Special items of business | 21.99%2.59B | -24.29%-102.83M | 66.49%905.54M | 1,458.11%562.39M | 150.17%2.12B | -99.51%-82.74M | 85.00%543.91M | -106.32%-41.41M | 37.58%847.5M | -106.57%-41.47M |
Net cash from operations | 21.99%2.59B | 35.67%1.77B | 66.49%905.54M | 203.78%3.05B | 150.17%2.12B | 171.88%1.31B | 85.00%543.91M | -38.89%1B | -23.41%847.5M | -42.51%480.95M |
Cash flow from investment activities | ||||||||||
Decrease in deposits (increase) | ---- | 103.89%313.46M | ---- | ---6.6B | ---- | -10,853.62%-8.07B | ---- | ---- | ---- | --75M |
Sale of fixed assets | ---- | -98.96%63K | ---- | 2,045.99%6.95M | ---- | 1,923.49%6.03M | ---- | 1,017.24%324K | ---- | 3,211.11%298K |
Purchase of fixed assets | ---- | -129.25%-759.07M | ---- | -180.93%-955.51M | ---- | -91.17%-331.12M | ---- | -30.87%-340.12M | ---- | -112.85%-173.21M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.93M | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.67%2.75B | ---- | ---- |
Cash on investment | ---- | ---- | ---- | 54.06%-2.39B | ---- | ---- | ---- | -32.31%-5.21B | ---- | ---- |
Other items in the investment business | 86.31%-1.29B | -227,507.58%-150.22M | 86.79%-523.46M | ---- | -351.88%-9.45B | ---66K | -1,527.30%-3.96B | ---- | ---2.09B | ---- |
Net cash from investment operations | 86.31%-1.29B | 92.90%-595.77M | 86.79%-523.46M | -252.86%-9.94B | -351.88%-9.45B | -8,469.56%-8.39B | -1,527.30%-3.96B | -367.98%-2.82B | -159.52%-2.09B | 41.50%-97.91M |
Net cash before financing | 117.64%1.29B | 116.64%1.18B | 111.18%382.08M | -280.01%-6.89B | -489.34%-7.33B | -1,949.09%-7.08B | -6,871.10%-3.42B | -274.46%-1.81B | -513.54%-1.24B | -42.76%383.04M |
Cash flow from financing activities | ||||||||||
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.20%180.17M |
Dividends paid - financing | ---- | ---- | ---- | ---562.9M | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---293.07M | ---- | 92.18%-71.84M | ---- | ---- | ---- | -7,832.44%-918.89M | ---- | -2,213.38%-267.98M |
Other items of the financing business | -3,841.45%-940.19M | 54.66%106.64M | -328.39%-104.58M | -12.80%217.71M | 160.88%25.13M | --68.96M | 402.95%45.79M | 593.99%249.66M | ---41.28M | ---- |
Net cash from financing operations | -3,841.45%-940.19M | -370.36%-186.43M | -328.39%-104.58M | 37.69%-417.02M | 160.88%25.13M | 178.52%68.96M | 402.95%45.79M | -110.41%-669.23M | -100.64%-41.28M | -101.37%-87.82M |
Effect of rate | -175.00%-9.23M | 174.82%7.53M | 97.35%-3.29M | -96.66%29.79M | -100.30%-3.36M | -99.49%2.74M | -177.98%-124.18M | 801.77%892.84M | 2,214.94%1.1B | 5,635.97%537.12M |
Net Cash | 104.83%352.43M | 114.14%991.9M | 108.23%277.5M | -194.38%-7.31B | -468.45%-7.3B | -2,475.76%-7.01B | -5,759.90%-3.37B | -133.23%-2.48B | -119.15%-1.28B | -95.83%295.22M |
Begining period cash | -74.64%2.47B | -74.64%2.47B | -74.64%2.47B | -14.02%9.75B | -14.02%9.75B | -14.02%9.75B | -14.02%9.75B | 183.67%11.34B | 183.67%11.34B | 183.67%11.34B |
Cash at the end | 15.20%2.82B | 26.69%3.47B | -56.08%2.75B | -74.64%2.47B | -78.09%2.44B | -77.49%2.74B | -44.93%6.25B | -14.02%9.75B | 3.74%11.16B | 9.79%12.17B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.